Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac

Background. A meningococcal group A conjugate vaccine, PsA-TT (MenAfriVac), developed through the Meningitis Vaccine Project and manufactured by the Serum Institute of India, Ltd, was tested in multiple clinical trials conducted mainly in Africa. The impact of age at which subjects were vaccinated o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yuxiao, Plikaytis, Brian D., Preziosi, Marie-Pierre, Borrow, Ray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639503/
https://www.ncbi.nlm.nih.gov/pubmed/26553685
http://dx.doi.org/10.1093/cid/civ601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639503/
https://www.ncbi.nlm.nih.gov/pubmed/26553685
http://dx.doi.org/10.1093/cid/civ601

Ejemplares similares